CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENTConfidential Treatment Requested • February 17th, 2017 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 17th, 2017 Company Industry JurisdictionTHIS LICENSE AGREEMENT (this “Agreement”) dated as of October 24, 2016 (the “Effective Date”) is entered into between Vanda Pharmaceuticals Inc., a Delaware corporation with an address at 2200 Pennsylvania Avenue, N.W., Washington, DC 20037, on behalf of itself and its Affiliates (collectively, “Vanda”), and Taro Pharmaceuticals USA, Inc., a New York corporation, with a place of business at Three Skyline Drive, Hawthorne, NY 10532 (“Taro USA”) and Taro Pharmaceutical Industries Ltd., a corporation organized and existing under the laws of Israel, with a place of business at 14 Hakitor Street, Haifa Bay, 2624761, Israel (“Taro Israel”) on behalf of themselves and each of their Affiliates (collectively, “Taro”).
CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENTLicense Agreement • February 17th, 2017 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 17th, 2017 Company Industry JurisdictionTHIS LICENSE AGREEMENT (this “Agreement”) dated as of December 7, 2016 (the “Effective Date”) is entered into between Vanda Pharmaceuticals Inc., a Delaware corporation with an address at 2200 Pennsylvania Avenue, N.W., Washington, DC 20037, on behalf of itself and its Affiliates (collectively, “Vanda”), and Apotex Inc., a corporation organized and existing under the laws of Canada, with a place of business at 150 Signet Drive, Toronto, Ontario M9L 1T9, Canada, and Apotex Corp., a Delaware corporation with a place of business at 2400 North Commerce Parkway, Suite 400, Weston, FL 33326, on behalf of themselves and each of their Affiliates (collectively, “Apotex”).